17.74 USD
+0.66 (+3.86%)
17.74 USD
0 (0%)
Overall SDGR gets a fundamental rating of 3 out of 10. We evaluated SDGR against 35 industry peers in the Health Care Technology industry. SDGR has a great financial health rating, but its profitability evaluates not so good. SDGR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SDGR has reported negative net income.
SDGR had a negative operating cash flow in the past year.
In the past 5 years SDGR reported 4 times negative net income.
SDGR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
SDGR has a Return On Assets of -26.92%. This is in the lower half of the industry: SDGR underperforms 60.00% of its industry peers.
SDGR has a Return On Equity of -54.77%. This is comparable to the rest of the industry: SDGR outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROIC | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 58.16%, SDGR is in line with its industry, outperforming 48.57% of the companies in the same industry.
In the last couple of years the Gross Margin of SDGR has grown nicely.
The Profit Margin and Operating Margin are not available for SDGR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SDGR has been increased compared to 1 year ago.
Compared to 5 years ago, SDGR has more shares outstanding
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of 0.99, we must say that SDGR is in the distress zone and has some risk of bankruptcy.
SDGR has a Altman-Z score of 0.99. This is comparable to the rest of the industry: SDGR outperforms 60.00% of its industry peers.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.99 |
ROIC/WACCN/A
WACC9.8%
2.3 Liquidity
A Current Ratio of 3.25 indicates that SDGR has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.25, SDGR is doing good in the industry, outperforming 74.29% of the companies in the same industry.
A Quick Ratio of 3.25 indicates that SDGR has no problem at all paying its short term obligations.
The Quick ratio of SDGR (3.25) is better than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.82% over the past year.
SDGR shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.90%.
The Revenue has been growing by 19.41% on average over the past years. This is quite good.
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
3.2 Future
The Earnings Per Share is expected to grow by 13.75% on average over the next years. This is quite good.
Based on estimates for the next years, SDGR will show a quite strong growth in Revenue. The Revenue will grow by 19.77% on average per year.
EPS Next Y7.29%
EPS Next 2Y12.07%
EPS Next 3Y12.08%
EPS Next 5Y13.75%
Revenue Next Year23.48%
Revenue Next 2Y21.65%
Revenue Next 3Y17.28%
Revenue Next 5Y19.77%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
SDGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SDGR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SDGR's earnings are expected to grow with 12.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.07%
EPS Next 3Y12.08%
5. Dividend
5.1 Amount
SDGR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.74
+0.66 (+3.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners108.15%
Inst Owner Change-1.81%
Ins Owners2.65%
Ins Owner Change0.53%
Market Cap1.31B
Revenue(TTM)256.95M
Net Income(TTM)-175.99M
Analysts80
Price Target27.44 (54.68%)
Short Float %15.94%
Short Ratio8.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.11%
Min EPS beat(2)24.66%
Max EPS beat(2)37.55%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-28.59%
Max EPS beat(4)37.55%
EPS beat(8)5
Avg EPS beat(8)6.18%
EPS beat(12)8
Avg EPS beat(12)16.99%
EPS beat(16)10
Avg EPS beat(16)13.2%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.23%
Max Revenue beat(2)3.3%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)3.23%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)7
Avg Revenue beat(12)1.23%
Revenue beat(16)11
Avg Revenue beat(16)6.23%
PT rev (1m)-4.31%
PT rev (3m)-1.47%
EPS NQ rev (1m)20%
EPS NQ rev (3m)23.93%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.09 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.07 | ||
| P/tB | 4.13 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.41
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS3.49
BVpS4.36
TBVpS4.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% | ||
| FCFM | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 35.82% | ||
| Cap/Sales | 0.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 0.99 |
F-Score3
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
EPS Next Y7.29%
EPS Next 2Y12.07%
EPS Next 3Y12.08%
EPS Next 5Y13.75%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
Revenue Next Year23.48%
Revenue Next 2Y21.65%
Revenue Next 3Y17.28%
Revenue Next 5Y19.77%
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.01%
EBIT Next 3Y17.97%
EBIT Next 5YN/A
FCF growth 1Y97.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.1%
OCF growth 3YN/A
OCF growth 5YN/A
SCHRODINGER INC / SDGR FAQ
What is the ChartMill fundamental rating of SCHRODINGER INC (SDGR) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SDGR.
What is the valuation status of SCHRODINGER INC (SDGR) stock?
ChartMill assigns a valuation rating of 0 / 10 to SCHRODINGER INC (SDGR). This can be considered as Overvalued.
What is the profitability of SDGR stock?
SCHRODINGER INC (SDGR) has a profitability rating of 1 / 10.
Can you provide the financial health for SDGR stock?
The financial health rating of SCHRODINGER INC (SDGR) is 7 / 10.
What is the earnings growth outlook for SCHRODINGER INC?
The Earnings per Share (EPS) of SCHRODINGER INC (SDGR) is expected to grow by 7.29% in the next year.